Korean drug makers rebound in first quarter
Published: 2013-06-03 07:00:00
Updated: 2013-06-03 07:00:00
The nation’s 42 listed pharmaceutical firms may have bottomed out in earnings in the first quarter as their operating profits have shown signs of improvement on the back of decreased promotion expenses, figures showed Thursday.
According to Yakup.com, a pharmaceutical information portal, the c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
